Candida Species Distribution of Clinical Specimens in Banda Aceh, Indonesia

Suhartono Suhartono(1), Wilda Mahdani(2), Aderiana Masthura(3), Iman Rusmana(4),

DOI: https://doi.org/10.15294/biosaintifika.v12i2.23758


(1) Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala
(2) Microbiology Departement of Medical Faculty, Universitas Syiah Kuala
(3) Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala
(4) Departement of Biology, Faculty of Mathematics and Natural Sciences, IPB University

Abstract

Candidiasis has become increasingly widespread in the community alongside with the developing resistance of Candida sp. to some antifungals. A prevalence study in the present research is required to surveil the distribution of Candida-related infections to administrate the appropriate antifungal treatments. The objective of this research was to determine the species distribution of candidiasis with their antifungal susceptibility isolated from clinical specimens at the Zainoel Abidin Hospital (ZAH) Banda Aceh, Indonesia. The clinical specimens were from inpatients and outpatients in the hospital during January to June 2019. The identification of Candida species and antifungal sensitivity assay were conducted by using VITEK® 2 Compact. Of a total of 68 isolates, there were six species of Candida with the highest species prevalence was Candida tropicalis (52.94%). Additionally, the highest prevalence of candidiasis came from urine specimen (54.41%) and mostly from inpatients in the internal medicine unit (54.41%). Candidiasis occurred predominantly in men (58.82%) and during adulthood (55.88%). The antibiogram of Candida sp. shows a high percentage of sensitivity towards some antifungals including fluconazole (100%), voriconazole (100%), caspofungin (100%), micafungin (100%), amphotericin B (99.5%), and flucytosine (100%). From this result, it can be concluded that candidiasis cases in the ZAH Banda Aceh, Indonesia has prevalently occurred with the few antifungal therapies for candidiasis of were still effective empirically and definitively. This is an initial study of Candida prevalence within different clinical samples in Banda Aceh and the study is expected to be a basis for prevention and control of Candida-related infections in the area.

Keywords

Candidiasis; Fungal Susceptibility; Species Distribution

Full Text:

PDF

References

Berkow, E. L., & Lockhart, S. R. (2017). Fluconazole resistance in Candida species: a current perspective. Infection and drug resistance, 10, 237-245. doi:10.2147/IDR.S118892

Bouza, E., Guinea, J., & Guembe, M. (2015). The role of antifungals against candida biofilm in catheter-related candidemia. Antibiotics, 4(1), 1-17. Retrieved from https://www.mdpi.com/2079-6382/4/1/1

Bravo Ruiz, G., Ross, Z. K., Gow, N. A. R., & Lorenz, A. (2020). Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere, 5(2), e00151-00120. doi:10.1128/mSphere.00151-20

Byadarahally Raju, S., & Rajappa, S. (2011). Isolation and identification of Candida from the oral cavity. ISRN dentistry, 2011.

Calderone, R. A., & Fonzi, W. A. (2001). Virulence factors of Candida albicans. Trends in Microbiology, 9(7), 327-335. doi:https://doi.org/10.1016/S0966-842X(01)02094-7.

Deorukhkar, S., & Roushani, S. (2017). Fluconazole resistance in Candida Species: Ten year’s experience at a rural tertiary care teaching hospital in India. Journal of Infectious Diseases and Pathogenesis, 1, 102.

Esmailzadeh, A., Zarrinfar, H., Fata, A., & Sen, T. (2018). High prevalence of Candiduria due to non-albicans Candida Species among diabetic patients: A matter of concern? Journal of Clinical Laboratory Analysis, 32(4), e22343. doi:10.1002/jcla.22343.

Frías-De-León, M. G., Martínez-Herrera, E., Acosta-Altamirano, G., Arenas, R., & Rodríguez-Cerdeira, C. (2019). Superficial candidosis by Candida duobushaemulonii: An emerging microorganism. Infection, Genetics and Evolution, 75, 103960. doi:https://doi.org/10.1016/j.meegid.2019.103960.

Karasuno, T., Sata, H., Noda, Y., Imakita, M., & Yasumi, M. (2019). Invasive candidiasis leading to gastric perforation in an immunocompromised patient. IDCases, 18, e00627. doi:https://doi.org/10.1016/j.idcr.2019.e00627

Kim, G.-Y., Jeon, J.-S., & Kim, J. K. (2016). Isolation frequency characteristics of Candida species from clinical specimens. Mycobiology, 44(2), 99-104.

Martins, N., Ferreira, I. C. F. R., Barros, L., Silva, S., & Henriques, M. (2014). Candidiasis: Predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia, 177(5), 223-240. doi:10.1007/s11046-014-9749-1

Mavor, A. L., Thewes, S., & Hube, B. (2005). Systemic fungal infections caused by Candida Species: Epidemiology, infection process and virulence attributes. Current Drug Targets, 6(8), 863-874. doi:10.2174/138945005774912735

Nett, J. E. (2016). The host’s reply to Candida biofilm. Pathogens, 5(1), 33. Retrieved from https://www.mdpi.com/2076-0817/5/1/33.

Reza, N. R., Tantari, S., & Basuki, S. (2017). In vitro susceptibilty test of fluconazole to Candida spp in patients with oropharyngeal candidiasis and HIV/AIDS with Vitek II. Berkala Ilmu Kesehatan Kulit dan Kelamin, 29(3), 234-242.

Sahal, G., & Bilkay, I. S. (2018). Distribution of clinical isolates of Candida spp. and antifungal susceptibility of high biofilm-forming Candida Isolates. Revista da Sociedade Brasileira de Medicina Tropical, 51, 644-650. Retrieved from http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000500644&nrm=iso.

Sanguinetti, M., Posteraro, B., & Lass-Flörl, C. (2015). Antifungal drug resistance among Candida species: Mechanisms and clinical impact. Mycoses, 58(S2), 2-13. doi:10.1111/myc.12330.

Shin, H.-S., Park, Y.-B., & Shin, D.-S. (2010). Isolation frequency of Candida species from clinical specimens. The Korean Journal of Mycology, 38(2), 146-151.

Singh, S., Fatima, Z., & Hameed, S. (2015). Predisposing factors endorsing Candida Infections. Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive, 23(3), 211-223.

Sorgo, A. G., Heilmann, C. J., Dekker, H. L., Bekker, M., Brul, S., de Koster, C. G., Klis, F. M. (2011). Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans. Eukaryotic Cell, 10(8), 1071-1081. doi:10.1128/ec.05011-11.

Tsui, C., Kong, E. F., & Jabra-Rizk, M. A. (2016). Pathogenesis of Candida albicans biofilm. Pathogens and Disease, 74(4). doi:10.1093/femspd/ftw018

Valiathan, R., Ashman, M., & Asthana, D. (2016). Effects of ageing on the immune system: Infants to Elderly. Scandinavian Journal of Immunology, 83(4), 255-266. doi:10.1111/sji.12413.

Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Kovács, R. (2020). Candida biofilm production is associated with higher mortality in patients with candidaemia. Mycoses, 63(4), 352-360. doi:10.1111/myc.13049

Wantini, S., & Rani, T. S. (2017). Gambaran Jamur Candida albicans dalam urine penderita diabetes melllitus di RSUD Jendral Hamad Yani, Kota Metro. 2017, 5(2), 5. doi:10.26630/jak.v5i2.463

Zarrin, M., & Mahmoudabadi, A. Z. (2009). Invasive Candidiasis; a review article. Jundishapur Journal of Microbiology, 2(1), 1.

Zuza-Alves, D. L., Silva-Rocha, W. P., & Chaves, G. M. (2017). An update on Candida tropicalis based on basic and clinical approaches. Frontiers in Microbiology, 8(1927). doi:10.3389/fmicb.2017.01927.

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.